Expert Insight
The Venture Capital Model for Life Sciences Is “Dead” – NLS Days 2025
At Nordic Life Science Days (NLSDays), a panel of leading Nordic investors and biopharma leaders explored how Europe’s life science financing landscape is evolving. Moderated by Renee Lucander, CEO of Hansa Biopharma, the discussion brought together Sonia Benhamida (Managing Director,
16 October 2025
